Abstract

Using molecular imaging of immunolabeled plasmonic nanoparticles bound by cell surface receptors, we compare epidermal growth factor receptor expression, an indicator of cancerous activity, of both human epithelial carcinoma and brain tumor cell lines.

© 2007 OSA

PDF Article